Brief: Axsome Therapeutics Settles Sunosi® (Solriamfetol) Patent Litigation With Alkem Laboratories Ltd.
17/02/2026 12:30
Feb 17 (Reuters) - Axsome Therapeutics Inc AXSM.O: AXSOME THERAPEUTICS SETTLES SUNOSI® (SOLRIAMFETOL) PATENT LITIGATION WITH ALKEM LABORATORIES LTD. AXSOME THERAPEUTICS INC - PATENT LITIGATION AGAINST ANOTHER PARTY RELATED TO SUNOSI PENDING Source text: ID:nGNX9YyFWv Further company coverage: AXSM.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Axsome Therapeutics
See all newsUS RESEARCH ROUNDUP-Bright Minds Biosciences, Marvell Technology, Oracle Corporation
Axsome Therapeutics Q3 revenue rises on Auvelity and Sunosi
US RESEARCH ROUNDUP-Apple, Kaiser Aluminum, Reliance
Axsome Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Axsome Therapeutics Q2 revenue rises on AUVELITY growth